He has been active in neurobiology for more than two decades. He has published more than 30 peer-reviewed papers and given numerous presentations at national and international meetings. He pioneered the combined use of stem cells and silk fibroin-based polymers for stroke therapeutics.

 

Presently his work focuses on the study of brain spreading depression/depolarization waves, EEG and sleep/wake cycle regulation and cortical field potentials as biomarkers for early diagnosis/prognosis in stroke and Alzheimer´s disease. He uses brain engineering approaches for biomaterial-based drug/cell delivery to support the sustained administration of neuroprotective compounds to salvage the cerebral tissue at risk of damage or/and neurogenic factors and diverse rehabilitative paradigms to rewire neural networks enhancing brain plasticity and recovery in stroke, Alzheimer´s and Parkinson´s diseases.